Michael Kahn

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 8

Top Topics

Epithelial Mesenchymal Transition

Mild Cognitive Impairment

Top Venues

Current molecular pharmacology

Cancer research

This page only lists publications with an associated author ORCID identifier.

Publications

Yufan Zhou, Zhijing He, Tian Li, Lavanya Choppavarapu, Xiaohui Hu, Ruifeng Cao, Gustavo W Leone, Michael Kahn, Victor X Jin
3D Chromatin Alteration by Disrupting β-Catenin/CBP Interaction Is Enriched with Insulin Signaling in Pancreatic Cancer. Cancers 16 (12) (2024)
Yufan Zhou, Zhijing He, Tian Li, Lavanya Choppavarapu, Xiaohui Hu, Ruifeng Cao, Gustavo W Leone, Michael Kahn, Victor X Jin
3D Chromatin Alteration by Disrupting β-Catenin/CBP Interaction Is Enriched with Insulin Signaling in Pancreatic Cancer. Cancers 16 (12) (2024)
Yufan Zhou, Zhijing He, Tian Li, Lavanya Choppavarapu, Xiaohui Hu, Ruifeng Cao, Gustavo W Leone, Michael Kahn, Victor X Jin
3D Chromatin Alteration by Disrupting β-Catenin/CBP Interaction Is Enriched with Insulin Signaling in Pancreatic Cancer. Cancers 16 (12) (2024)
Yufan Zhou, Zhijing He, Tian Li, Lavanya Choppavarapu, Xiaohui Hu, Ruifeng Cao, Gustavo W Leone, Michael Kahn, Victor X Jin
3D Chromatin Alteration by Disrupting β-Catenin/CBP Interaction Is Enriched with Insulin Signaling in Pancreatic Cancer. Cancers 16 (12) (2024)
Erasmus Kofi Poku, Masaya Ono, Yusuke Higuchi, Junie Chea, Elizabeth Melendez, Jia-Ling Teo, Cu Nguyen, Nyam-Osor Chimge, Michael Kahn
Differential Kat3 Coactivator Usage Regulates Brain Metabolism and Neuronal Differentiation. Current molecular pharmacology (2023)
Michael Kahn
A Metabolic Smorgasbord Drives and Sustains CSC Heterogeneity. Cancers 15 (2) (2023)
Michael Kahn
A Metabolic Smorgasbord Drives and Sustains CSC Heterogeneity. Cancers 15 (2) (2023)
Anil Belur Nagaraj, Matthew Knarr, Sreeja Sekhar, R Shae Connor, Peronne Joseph, Olga Kovalenko, Alexis Fleming, Arshia Surti, Elmar Nurmemmedov, Luca Beltrame, Sergio Marchini, Michael Kahn, Analisa DiFeo
The miR-181a-SFRP4 Axis Regulates Wnt Activation to Drive Stemness and Platinum Resistance in Ovarian Cancer. Cancer research 81 (8) (2021)